Trial intelligence / Profile preview

Propranolol for Memory Reconsolidation Blockade in Substance Dependence

NCT01634347Phase 2Completed

Sponsor
Douglas Mental Health University Institute
Start
Jan 2012
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of propranolol in substance dependence, sponsored by Douglas Mental Health University Institute. Started Jan 2012; status: completed.

02

Drugs

propranolol
03

Conditions

substance dependence

Beyond the preview

Go deeper on NCT01634347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01634347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call